Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bioconjugate Chemistry|November 15, 2024
Light-Driven Installation of Aminooxyhomolysine on Histones and Its Application for Synthesizing Stable and Site-Specific 3'-DNA-Histone Cross-LinksYangxue Liu, Ying Peng, Zhishuo Wang, et al.The Journal of Organic Chemistry|November 28, 2018
Synthesis of Functionalized Chromene and Chroman Derivatives via Cesium Carbonate Promoted Formal [4 + 2] Annulation of 2'-Hydroxychalcones with AllenoatesHossein Rouh, Yangxue Liu, Nandakumar Katakam, et al.Microorganisms|November 27, 2025
Potential Biomarkers and Underlying Pathogenesis of <i>Mycoplasma synoviae</i> Infection: Insights from Metabolomics AnalysisXiaona Wei, Mengyao Sun, Kuan Zhang, et al.Chemistry, an Asian Journal|February 19, 2020
Synthesis of Diastereoenriched α-Aminomethyl Enaminones via a Brønsted Acid-Catalyzed Asymmetric aza-Baylis-Hillman Reaction of Chiral N-Phosphonyl IminesYangxue Liu, Sultan Ahmed, Xiao-Yan Qin, et al.The Journal of Organic Chemistry|June 27, 2015
I2/KI-Mediated Oxidative N-N Bond Formation for the Synthesis of 1,5-Fused 1,2,4-Triazoles from N-Aryl AmidinesLina Song, Xianhai Tian, Zhigang Lv, et al.Virology Journal|July 4, 2026
A receptor-Fc based SFV replicon Trim-Away platform for targeted viral protein degradationYiming Han, Qisheng Dong, Zhen Tian, et al.Research (Washington, D.C.)|September 25, 2019
Multilayer <i>3D</i> Chirality and Its Synthetic AssemblyGuanzhao Wu, Yangxue Liu, Zhen Yang, et al.Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|December 13, 2024
Highly efficient adsorption of natural organic matter from aqueous solutions by macroporous weakly basic anion exchange resin: performance, mechanism, and fixed - bed columnXingdi Ma, Yangxue Liu, Zhonglin Chen, et al.European Journal of Medicinal Chemistry|June 30, 2015
Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agentsZhigang Lv, Wu He, Xianhai Tian, et al.Medical Oncology (Northwood, London, England)|July 1, 2026
Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor controlYiming Han, Qi Guo, Han Cao, et al.Pageof 2